ECSP961966A - NEW CRYSTALLINE VARIANT FROM CDCH. PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT - Google Patents

NEW CRYSTALLINE VARIANT FROM CDCH. PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT

Info

Publication number
ECSP961966A
ECSP961966A ECSP961966A ECSP961966A EC SP961966 A ECSP961966 A EC SP961966A EC SP961966 A ECSP961966 A EC SP961966A EC SP961966 A ECSP961966 A EC SP961966A
Authority
EC
Ecuador
Prior art keywords
cdch
production
pharmaceutical preparations
procedure
contain
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Alfons Grunenberg
Patrick Bosche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961966 priority Critical patent/ECSP961966A/en
Publication of ECSP961966A publication Critical patent/ECSP961966A/en

Links

Abstract

La invención se refiere al nuevo monohidrato del ácido 1-ciclopropil -7- ([s,s]-2,8 - diazabiciclo [4.3.0] non -8- il) -6- flúor - 1,4 -dihidro -8- metoxi-4-oxo -3- quinolincarboxílico clorhidrato (cdch) a un procedimiento para su producción y a preparados farmacéuticos que contienen este monohidrato como sustancias activas.The invention relates to the novel 1-cyclopropyl -7- ([s, s] -2,8-diazabicyclo [4.3.0] non -8-yl) -6-fluoro-1,4-dihydro -8 monohydrate - methoxy-4-oxo -3- quinolincarboxylic hydrochloride (cdch) to a process for its production and to pharmaceutical preparations containing this monohydrate as active substances.

ECSP961966 1996-12-11 1996-12-11 NEW CRYSTALLINE VARIANT FROM CDCH. PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT ECSP961966A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961966 ECSP961966A (en) 1996-12-11 1996-12-11 NEW CRYSTALLINE VARIANT FROM CDCH. PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961966 ECSP961966A (en) 1996-12-11 1996-12-11 NEW CRYSTALLINE VARIANT FROM CDCH. PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT

Publications (1)

Publication Number Publication Date
ECSP961966A true ECSP961966A (en) 1997-12-23

Family

ID=42042692

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961966 ECSP961966A (en) 1996-12-11 1996-12-11 NEW CRYSTALLINE VARIANT FROM CDCH. PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT

Country Status (1)

Country Link
EC (1) ECSP961966A (en)

Similar Documents

Publication Publication Date Title
CU22774A3 (en) NEW CRYSTAL VARIANTE OF THE CDCH, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT
HUT68251A (en) Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines and pharmaceutical compositions containing them
IL157940A0 (en) Drugs containing triazaspiro [5.5] undecane derivatives as the active ingredient
CA2350073A1 (en) Ccr5 modulators
TR200101103T2 (en) Controlled release pharmaceutical formulations containing CGMP PDE-Inhibitor
UA32512C2 (en) Xanthine derivatives, a PROCESS for PREPARATION thereof and A pharmaceutical composition
TR200200785T2 (en) 8-Phenyl-6,9-dihydro- [1,2,4] triazolo [3,4-i] purin-5-one derivatives
DK0495982T3 (en) Bicyclic pyrimidine derivative, process for its preparation and pharmaceutical composition comprising this as an active ingredient
UY25792A1 (en) PHARMACEUTICAL PREPARATION OF MOXIFLOXACIN.
HRP20020330B1 (en)
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
IL146104A0 (en) Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same
HRP20010969B1 (en) Novel piperazinylalkylthiopyrimidine derivatives,
MXPA02003162A (en) Stable calcitriol solution for packaging in vials.
ECSP961966A (en) NEW CRYSTALLINE VARIANT FROM CDCH. PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN IT
DE59010302D1 (en) R - (-) - 1- (5-hydroxyhexyl) -3-methyl-7-propylxanthine, process for its preparation and pharmaceutical compositions containing the same
EP1084710A4 (en) Remedies for male sterility
SG153894G (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
AP9901472A0 (en) Crystalline pharmaceutical product.
HUP0001308A3 (en) (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents, process for their preparation and pharmaceutical compositions containing the same
UA32583C2 (en) Derivatives of arylthioalkylthiopyridine
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
EP0523013A3 (en) Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases
HUP0202106A2 (en) Thienopyranecarboxamide derivatives, process for the preparation thereof, pharmaceutical compositions containing them
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS